OraSure Technologies, Inc. said consolidated net revenues increased 14% to $30.9 million for the three months ended September 30, 2026, while operating loss narrowed to $13.0 million from $16.1 million.
OSUR · Orasure Technologies Inc · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Orashure Technologies reported third-quarter revenue of $30.9 million, up 14% year-over-year, and now expects operating cash-flow break-even in the second half of 2027 instead of entering 2027.
OraSure Technologies reported net revenues of $30.9 million, up 14%, and an operating loss of $13.0 million versus $16.1 million. In June 2026, it received FDA 510(k) clearance for its Colli-Pee™•Dx Urine Collection Kit.
OraSure Technologies announced third-quarter 2026 revenue of $30.9 million, up 14% year-over-year, with GAAP gross margin of 45.2% and GAAP net loss of $13.1 million. It guided Q4 2026 revenue from $30.0 million to $32.0 million.